Approval · Notice of Compliance 1287 · 2000
FLAGYSTATIN: Notice of Compliance 1287
Issued October 24, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1287
- Date
- October 24, 2000
- Company
- Aventis Pharma Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Trichomonacide-moniliacide
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLAGYSTATIN | 01926845 | Cancelled Post Market |
| FLAGYSTATIN | 01926837 | Cancelled Post Market |
| FLAGYSTATIN | 01926829 | Marketed |
Medicinal ingredients
- METRONIDAZOLE 500 MG per DOSE
- NYSTATIN 100,000 UNIT per DOSE
- METRONIDAZOLE 500 MG per SUP
- NYSTATIN 100,000 UNIT per SUP